Abstract
The emergence and spread of carbapenem-resistant Enterobacteriaceae in the world are a major concern. We investigated 5 isolates of Enterobacter cloacae that were resistant to all clinically available antimicrobial agents, except polymyxin B. The MICs of imipenem and aminoglycosides were >32 and >256 mg/L, respectively. All of the isolates produced 5 extended-spectrum beta-lactamase (ESBLs) with pIs of 5.4 (TEM-1), 6.7 (KPC-2), 8.2 (SHV-12), 8.4 (CTX-M-14), and ArmA 16S rRNA methylase. bla(KPC-2) was located on a large nonconjugative plasmid, whereas armA was located on another conjugative plasmid. Although carbapenem-resistant Enterobacteriaceae remains rare, the emergence of this group of organism merits monitoring.
2010 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aminoglycosides / pharmacology*
-
Bacterial Proteins / genetics
-
Bacterial Proteins / metabolism
-
Carbapenems / pharmacology*
-
Drug Resistance, Multiple, Bacterial
-
Enterobacter cloacae / drug effects*
-
Enterobacter cloacae / enzymology*
-
Enterobacter cloacae / genetics
-
Enterobacter cloacae / isolation & purification
-
Enterobacteriaceae Infections / microbiology
-
Humans
-
Methyltransferases / genetics*
-
Methyltransferases / metabolism
-
Microbial Sensitivity Tests
-
Plasmids / genetics*
-
RNA, Ribosomal / genetics
-
RNA, Ribosomal / metabolism
-
beta-Lactamases / genetics*
-
beta-Lactamases / metabolism
Substances
-
Aminoglycosides
-
Bacterial Proteins
-
Carbapenems
-
RNA, Ribosomal
-
Methyltransferases
-
beta-lactamase KPC-2
-
beta-Lactamases